Screening diseases such as cancer without using slow, invasive, and expensive methods such as MRI-, CT- or PET-scans, but instead with just a single drop of blood? Thanks to Nanotechnology-alumnus Dilu Mathew, this can be the future. His invention in UT’s NanoLab grew into the promising start-up ECSens, of which Dilu is now Chief Executive Officer. Listen to his story.

Listen to Dilu's Podcast 

Dilu studied the Master's in Nanotechnology.

.

Chat offline (info)
To use this functionality you first need to:
Accept cookies